Skip to content
10-Q/A

Quarterly Report

DUSA PHARMACEUTICALS INC

0001193125-12-332272

← back to feed
Filed
Aug 2, 2012 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Aug 1, 2012 25M sh
Shares Diluted Q2 2012 · Jun 30, 2012 26.91M sh
Shares Diluted Q2 2012 · Jun 30, 2012 26.9M sh
Shares Diluted Q2 2012 · Jun 30, 2011 26.81M sh
Shares Diluted Q2 2012 · Jun 30, 2011 26.33M sh
Capex Q2 2012 · Jun 30, 2012 $485.48K
Capex Q2 2012 · Jun 30, 2011 $210.2K
Operating Cash Flow Q2 2012 · Jun 30, 2012 $3.83M
Operating Cash Flow Q2 2012 · Jun 30, 2011 $3.67M
Cash And Equivalents Q2 2012 · Jun 30, 2012 $26.56M
Cash And Equivalents Q2 2012 · Dec 31, 2011 $24.42M
Cash And Equivalents Q2 2012 · Jun 30, 2011 $20.74M
Cash And Equivalents Q2 2012 · Dec 31, 2010 $8.88M
Stockholders Equity Q2 2012 · Jun 30, 2012 $31.09M
Stockholders Equity Q2 2012 · Dec 31, 2011 $28.28M
Current Liabilities Q2 2012 · Jun 30, 2012 $5.49M
Current Liabilities Q2 2012 · Dec 31, 2011 $6.47M
Total Liabilities Q2 2012 · Jun 30, 2012 $9.35M
Total Liabilities Q2 2012 · Dec 31, 2011 $9.74M
Current Assets Q2 2012 · Jun 30, 2012 $38.41M
Current Assets Q2 2012 · Dec 31, 2011 $36.19M
Total Assets Q2 2012 · Jun 30, 2012 $40.44M
Total Assets Q2 2012 · Dec 31, 2011 $38.02M
Eps Diluted Q2 2012 · Jun 30, 2012 $0.08
Eps Diluted Q2 2012 · Jun 30, 2012 $0.07
Eps Diluted Q2 2012 · Jun 30, 2011 $0.04
Eps Diluted Q2 2012 · Jun 30, 2011 $0.02
Eps Basic Q2 2012 · Jun 30, 2012 $0.09
Eps Basic Q2 2012 · Jun 30, 2012 $0.07
Eps Basic Q2 2012 · Jun 30, 2011 $0.05
Eps Basic Q2 2012 · Jun 30, 2011 $0.02
Sga Expense Q2 2012 · Jun 30, 2012 $2.87M
Sga Expense Q2 2012 · Jun 30, 2012 $5.96M
Sga Expense restated Q2 2012 · Jun 30, 2011 $2.55M
Sga Expense restated Q2 2012 · Jun 30, 2011 $5M
Rd Expense Q2 2012 · Jun 30, 2012 $2.21M
Rd Expense Q2 2012 · Jun 30, 2012 $4.26M
Rd Expense Q2 2012 · Jun 30, 2011 $1.11M
Rd Expense Q2 2012 · Jun 30, 2011 $2.43M
Net Income Q2 2012 · Jun 30, 2012 $2.18M
Net Income Q2 2012 · Jun 30, 2012 $1.85M
Net Income Q2 2012 · Jun 30, 2011 $1.11M
Net Income Q2 2012 · Jun 30, 2011 $505.7K
Operating Income Q2 2012 · Jun 30, 2012 $865.52K
Operating Income Q2 2012 · Jun 30, 2012 $2.45M
Operating Income restated Q2 2012 · Jun 30, 2011 $1.25M
Operating Income restated Q2 2012 · Jun 30, 2011 $2.85M
Gross Profit Q2 2012 · Jun 30, 2012 $9.95M
Gross Profit Q2 2012 · Jun 30, 2012 $21.3M
Gross Profit restated Q2 2012 · Jun 30, 2011 $8.2M
Gross Profit restated Q2 2012 · Jun 30, 2011 $17.55M
Cost Of Revenue Q2 2012 · Jun 30, 2012 $1.78M
Cost Of Revenue Q2 2012 · Jun 30, 2012 $3.85M
Cost Of Revenue restated Q2 2012 · Jun 30, 2011 $1.47M
Cost Of Revenue restated Q2 2012 · Jun 30, 2011 $3.1M